- Home
- PROP vs CTMX Comparison
PROP vs CTMX Comparison
Compare PROP & CTMX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PROP
- CTMX
- Stock Information
- Founded
- PROP 2001
- CTMX 2008
- Country
- PROP United States
- CTMX United States
- Employees
- PROP N/A
- CTMX N/A
- Industry
- PROP Investment Bankers/Brokers/Service
- CTMX Biotechnology: Pharmaceutical Preparations
- Sector
- PROP Finance
- CTMX Health Care
- Exchange
- PROP Nasdaq
- CTMX Nasdaq
- Market Cap
- PROP 168.7M
- CTMX 444.3M
- IPO Year
- PROP N/A
- CTMX 2015
- Fundamental
- Price
- PROP $2.99
- CTMX $2.27
- Analyst Decision
- PROP Strong Buy
- CTMX Strong Buy
- Analyst Count
- PROP 4
- CTMX 2
- Target Price
- PROP $8.75
- CTMX $5.00
- AVG Volume (30 Days)
- PROP 1.1M
- CTMX 2.7M
- Earning Date
- PROP 08-15-2025
- CTMX 08-07-2025
- Dividend Yield
- PROP N/A
- CTMX N/A
- EPS Growth
- PROP N/A
- CTMX 128.27
- EPS
- PROP N/A
- CTMX 0.49
- Revenue
- PROP $21,529,000.00
- CTMX $147,557,000.00
- Revenue This Year
- PROP $5,974.95
- CTMX N/A
- Revenue Next Year
- PROP $26.36
- CTMX N/A
- P/E Ratio
- PROP N/A
- CTMX $4.78
- Revenue Growth
- PROP N/A
- CTMX 23.81
- 52 Week Low
- PROP $2.91
- CTMX $0.40
- 52 Week High
- PROP $12.30
- CTMX $3.10
- Technical
- Relative Strength Index (RSI)
- PROP 36.67
- CTMX 50.77
- Support Level
- PROP $3.14
- CTMX $2.08
- Resistance Level
- PROP $4.09
- CTMX $2.44
- Average True Range (ATR)
- PROP 0.21
- CTMX 0.24
- MACD
- PROP -0.05
- CTMX -0.08
- Stochastic Oscillator
- PROP 24.32
- CTMX 19.12
About PROP Prairie Operating Co.
Prairie Operating Co is a Houston-based independent energy company engaged in the development and acquisition of oil and natural gas resources in the United States. The Company's assets and operations are concentrated in the oil and liquids-rich regions of the Denver-Julesburg (DJ) Basin, with a focus on the Niobrara and Codell formations. The Company is committed to the responsible development of its oil and natural gas resources and is focused on maximizing returns through consistent growth, capital discipline, and sustainable cash flow generation.
About CTMX CytomX Therapeutics Inc.
CytomX Therapeutics Inc a clinical-stage, oncology-focused biopharmaceutical company developing novel, masked, conditionally activated biologics designed to be localized to the tumor microenvironment. It is engaged in developing antibody therapeutics based on probody technology platforms. The company's probody technology platform creates proprietary cancer immunotherapies against clinically-validated targets and develops cancer therapeutics. Probody therapeutics are designed to take advantage of conditions in the tumor microenvironment to enhance the tumor-targeting features of an antibody and reduce drug activity in healthy tissues.